Bull case
The bull case prices AGX at 47x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where AGX stock could go
The bull case prices AGX at 47x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
At 36x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 39x multiple contraction could push AGX down roughly 63% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Argan is a specialized engineering and construction firm that builds power plants and renewable energy facilities. It generates revenue primarily from power industry services — engineering, procurement, and construction contracts for biomass, wind, and solar projects — with additional income from industrial fabrication and telecommunications infrastructure work. The company's competitive advantage lies in its deep expertise in complex power generation projects and its established relationships with independent power producers and utilities.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $2.50/$1.99 | +25.6% | $238M/$243M | -2.2% |
| Q4 2025 | $2.17/$2.05 | +5.9% | $251M/$264M | -4.8% |
| Q1 2026 | $3.47/$1.99 | +74.4% | $262M/$255M | +2.6% |
| Q2 2026 | $3.24/$2.31 | +40.3% | $291M/$256M | +13.6% |
AGX beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $666 — implies -9.9% from today's price.
| Metric | AGX | S&P 500 | Industrials | 5Y Avg AGX |
|---|---|---|---|---|
| Forward PE | 61.1x | 18.8x+225% | 21.2x+189% | — |
| Trailing PE | 75.9x | 24.4x+211% | 25.6x+197% | 21.7x+249% |
| PEG Ratio | 1.68x | 1.66x | 1.65x | — |
| EV/EBITDA | 73.2x | 15.2x+381% | 13.9x+427% | 15.2x+381% |
| Price/FCF | 25.2x | 20.7x+22% | 20.0x+26% | 12.7x+98% |
| Price/Sales | 11.0x | 3.1x+255% | 1.6x+602% | 2.2x+407% |
| Dividend Yield | 0.23% | 1.91% | 1.21% | 1.81% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolAGX generates $487M in free cash flow at a 46.7% margin — 59.7% ROIC signals a durable competitive advantage.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
The company's projected EPS has a confidence score of only 53/100, indicating uncertainty in revenue trajectory and margin path.
Argan disclosed 40 risk factors in its most recent earnings report, suggesting significant operational and financial challenges.
Despite a strong composite score of 76.3/100, the company's market cap of $4.2B ranks it #211, indicating potential competitive pressures.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Argan, Inc. reported strong revenue, earnings, and cash flow, with consistent growth in sales and net income year-over-year.
The company's experienced leadership enhances acquired businesses and positions them for sustained growth.
Kroker Equity Research published a bullish thesis on Argan, Inc., highlighting its potential for investment growth.
Argan's trailing P/E ratio of 42.17 indicates strong investor confidence and growth expectations.
Argan oil's versatility in culinary, skincare, and health applications supports demand and market potential.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
AGX AGX Argan, Inc. | $10.4B | 61.1x | +10.6% | 15.5% | Buy | -24.3% |
MYR MYRG MYR Group Inc. | $7.2B | 40.3x | +8.8% | 3.7% | Hold | -10.5% |
PWR PWR Quanta Services, Inc. | $105.4B | 50.2x | +13.2% | 3.7% | Buy | -4.0% |
MTZ MTZ MasTec, Inc. | $29.9B | 43.0x | +11.4% | 3.0% | Buy | +9.8% |
PRI PRIM Primoris Services Corporation | $5.5B | 20.9x | +7.2% | 3.3% | Buy | +50.8% |
WLD WLDN Willdan Group, Inc. | $1.3B | 21.6x | +8.1% | 8.2% | Buy | +32.0% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
AGX returns 0.3% total yield, led by a 0.23% dividend.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $1.50 | — | 0.2% | 0.7% |
| 2025 | $1.63 | +27.5% | 0.1% | 1.0% |
| 2024 | $1.27 | +21.4% | 2.1% | 4.5% |
| 2023 | $1.05 | +5.0% | 12.3% | 14.9% |
| 2022 | $1.00 | +33.3% | 3.4% | 6.1% |
Common questions answered from live analyst data and company financials.
Argan, Inc. (AGX) is rated Buy by Wall Street analysts as of 2026. Of 7 analysts covering the stock, 4 rate it Buy or Strong Buy, 3 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $559, implying -24.3% from the current price of $739. The bear case scenario is $273 and the bull case is $571.
The Wall Street consensus price target for AGX is $559 based on 7 analyst estimates. The high-end target is $600 (-18.8% from today), and the low-end target is $518 (-29.9%). The base case model target is $434.
AGX trades at 61.1x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals slightly expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for AGX in 2026 are: (1) Operational Risks — Argan disclosed 40 risk factors in its most recent earnings report, suggesting significant operational and financial challenges. (2) Earnings Uncertainty — The company's projected EPS has a confidence score of only 53/100, indicating uncertainty in revenue trajectory and margin path. (3) Market Position — Despite a strong composite score of 76. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates AGX will report consensus revenue of $1.2B (+10.6% year-over-year) and EPS of $9.90 (-12.9% year-over-year) for the upcoming fiscal year. The following year, analysts project $1.3B in revenue.
A confirmed upcoming earnings date for AGX is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Argan, Inc. (AGX) generated $487M in free cash flow over the trailing twelve months — a free cash flow margin of 46.7%. AGX returns capital to shareholders through dividends (0.2% yield) and share repurchases ($10M TTM).